Arcutis Biotherapeutics, Inc. (ARQT)

Arcutis Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	84.27	88.4	53.64	96.45	65.08	63.34
Short-Term Investments	278.17	183.46	355.95	290.61	219.36	37.93
Cash & Short-Term Investments	362.44	271.86	409.59	387.06	284.44	101.27
Cash Growth	34.90%	-33.63%	5.82%	36.08%	180.89%	98.79%
Accounts Receivable	43.41	25.81	8.46	-	-	-
Other Receivables	-	-	-	-	0.51	0.15
Receivables	43.41	25.81	8.46	-	0.51	0.15
Inventory	13.88	13.13	7.51	-	-	-
Prepaid Expenses	11.71	10.1	7.39	14.17	6.33	3.32
Restricted Cash	0.62	0.93	1.23	1.54	1.54	-
Other Current Assets	2.53	8.61	3.23	-	-	1.75
Total Current Assets	434.59	330.43	437.41	402.77	292.83	106.47
Property, Plant & Equipment	3.51	3.9	4.6	5.3	5.37	0.49
Other Intangible Assets	6.06	6.44	7.19	-	-	-
Other Long-Term Assets	0.6	0.6	0.08	0.08	0.08	0.05
Total Assets	444.76	341.37	449.27	408.15	298.27	107.01
Accounts Payable	7.94	11.99	8.83	7.35	7.14	1.41
Accrued Expenses	42.63	33.94	28.32	25.54	15.29	3.43
Current Portion of Leases	0.78	0.74	0.66	0.43	-	0.18
Other Current Liabilities	-	-	-	-	0.18	0.23
Total Current Liabilities	51.35	46.67	37.81	33.33	22.6	5.24
Long-Term Debt	203.81	201.8	197.77	72.35	-	-
Long-Term Leases	2.98	3.38	4.12	4.77	4.96	0.13
Other Long-Term Liabilities	0.19	0.85	-	0.03	0.08	0.18
Total Liabilities	258.33	252.7	239.69	110.48	27.65	5.55
Common Stock	0.01	0.01	0.01	0.01	0	-
Additional Paid-In Capital	1,256	1,071	930.43	706.23	472.57	1.24
Retained Earnings	-1,070	-981.9	-719.76	-408.31	-201.95	-66.27
Comprehensive Income & Other	-0.29	0	-1.09	-0.26	-0	-0
Total Common Equity	186.43	88.67	209.58	297.68	270.62	-65.03
Shareholders' Equity	186.43	88.67	209.58	297.68	270.62	101.46
Total Liabilities & Equity	444.76	341.37	449.27	408.15	298.27	107.01
Total Debt	207.56	205.92	202.54	77.56	4.96	0.31
Net Cash (Debt)	154.87	65.95	207.05	309.5	279.48	100.96
Net Cash Growth	140.29%	-68.15%	-33.10%	10.74%	176.83%	98.19%
Net Cash Per Share	1.59	0.95	3.76	6.26	7.84	54.77
Filing Date Shares Outstanding	116.89	96.81	61.08	50.38	50.08	37.95
Total Common Shares Outstanding	116.48	96.79	61.04	50.26	43.34	2.74
Working Capital	383.24	283.76	399.6	369.45	270.22	101.24
Book Value Per Share	1.60	0.92	3.43	5.92	6.24	-23.72
Tangible Book Value	180.36	82.23	202.39	297.68	270.62	-65.03
Tangible Book Value Per Share	1.55	0.85	3.32	5.92	6.24	-23.72
Machinery	-	1.79	1.36	1.12	0.52	0.14
Construction In Progress	-	-	-	-	0.3	-
Leasehold Improvements	-	1.57	1.57	1.57	1.28	0.16

Source: S&P Capital IQ. Standard template. Financial Sources.